Skip to main content
Fig. 7 | Stem Cell Research & Therapy

Fig. 7

From: Intravitreal administration of multipotent mesenchymal stromal cells triggers a cytoprotective microenvironment in the retina of diabetic mice

Fig. 7

The intravitreal administration of mesenchymal stromal cells (MSCs) reduces the retinal oxidative damage. Four and 12 weeks after the administration of MSCs or vehicle the retinas were dissected and the levels of a reactive oxygen species (ROS), b lipid peroxidation, c protein nitrosylation and d DNA oxidation were measured. Quantitative data correspond to mean ± SEM of eight eyes per group and per analyzed time. DM Diabetes mellitus, MDA malondialdehyde

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512